Events
-
October 28, 2022
EBRC SPA Presents Data and Engineering Biology: Operating at the Technical Interface
The EBRC Student and Postdoc Association is hosting a Data and Engineering Biology: Operating at the Technical Interface panel event, where researchers can connect with professionals who operate and lead […]
-
October 14, 2022
EBRC Global Forum 2.0
This is an invitation-only event. Register here MEETING OVERVIEW The second EBRC Global Forum for Engineering Biology: Review of Synthetic Biology/Bioeconomy National Strategies (EBRC Global Forum 2.0) will be […]
-
October 10, 2022
Synthetic Biology for Future Health
We are pleased to announce our new conference on synthetic biology. This conference will present how technologies from synthetic biology are delivering innovations across clinical health applications and leading towards […]
-
September 26, 2022
Global Open Genetic Engineering Competition (GOGEC)
GOGEC, a virtual conference, allows students to present their work and meet other synthetic biology students around the world without having to worry about registration fees. Projects can include any sort of synthetic biology work including engineering organisms, purely computational or software work, or building non-biological devices with biological applications.
-
September 26, 2022
Symposium on Innovation and Education for the Bioeconomy
Join local, state, and national leaders in education, government, and industry on October 27th, 2022 as we build a better and more sustainable future in the Appalachian Highlands.
-
September 26, 2022
EBRC 2022 Council Retreat
Reminder to EBRC Council members in industry, government, and academia, to register and book your travel for the EBRC 2022 Council Meeting.
-
September 26, 2022
iGEM 2022 Grand Jamboree
The iGEM Grand Jamboree is where the future of synthetic biology is showcased every year. This year, 350+ multidisciplinary teams from 40+ countries will be presenting their projects on how to solve local problems, all over the world, using synthetic biology.
-
July 26, 2022
3D Cell Culture Online
Our 3D Cell Culture congress incorporates key trends and innovative technologies to accelerate the adoption of 3D models in preclinical research via advanced development, validation and application strategies.
-
July 26, 2022
Oligonucleotide Chemistry & Therapeutics Symposium
An intensive 1-day meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research […]
-
May 23, 2022
Precision Medicine World Conference 2022 (PMWC)
Join the 2022 Precision Medicine World Conference on June 28-30,2022 located at the Santa Clara Convention Center! The program will include: Three-day Program Seven Simultaneous Tracks 400+ Speakers Awards Reception […]
-
March 23, 2022
2022 ASBMB Annual Meeting
Join thousands of scientists from multiple disciplines with shared research interests. Present your latest findings, hear inspiring lectures, participate in workshops, and form new bonds that will help you achieve the most important work of your career. Held in conjunction with Experimental Biology.
-
March 15, 2022
Climate and Sustainability Roadmap Virtual Writing Workshop 10
This virtual workshop will focus on filling in technical gaps and move us closer to completing the technical content of the Roadmap. Participants will review the identified technical gaps and fill in those gaps by drafting technical milestones, bottlenecks, and potential solutions.
-
March 11, 2022
Climate and Sustainability Roadmap In-person Workshop
This workshop is by invitation only, with a limited number of attendants. The workshop will focus on reviewing and revising our technical research roadmap to advance engineering biology tools and technologies that respond to the urgency of the climate crisis and promote long-term sustainability.
-
EBRC SPA Presents Transitioning to Business Roles Post-PhD Panel
The EBRC Student and Postdoc Association is hosting a Transitioning to Business Roles Post-PhD panel event, where researchers can connect with professionals who work in venture capital, consulting, business development, and technology transfer following a biotech graduate education. Join us virtually on April 6th, 2022 (2:00-3:30pm ET |11:00-12:30am PT) on GatherTown by registering here. Our diverse panel includes a broad range of business perspectives that will provide insights on how graduate students can begin to differentiate in preparation for these career paths.
Click here to view our flyer.
Please contact Eric South (esouth@bu.edu) if you have any questions.
Panelist Biographies
Sarah R. Carter, Ph.D.
LinkedIn
Dr. Carter is the Principal at Science Policy Consulting LLC where she focuses on societal and policy implications of emerging biotechnologies. Trained as a scientist, she has a detailed understanding of synthetic biology and tracks advances in biotechnology as they arise. She has 10+ years of experience working with policy frameworks related to biotechnologies and the increasingly diverse biotechnology industry, and has contributed to many policy projects and processes, including those organized by U.S. government agencies, non-profit and academic institutions, and others. Previously, she worked in the Policy Center of the J. Craig Venter Institute and in the Obama Administration’s White House Office of Science and Technology Policy (OSTP). Dr. Carter is a former AAAS Science and Technology Policy Fellow and a former Mirzayan Fellow of the National Academies. She earned her Ph.D. in Neuroscience from the University of California-San Francisco and her bachelor’s degree in Biology from Duke University.Travis D’Cruz, Ph.D., MSEM
LinkedIn
Dr. D’Cruz is a Senior Manager at Oncorus with an advanced background in life sciences research and several years of experience in facilitating technology commercialization. Travis is adept at spearheading partnership discussions to execute productive deals, along with experience in leading asset-focused partnering discussions with large pharma, supporting strategic collaborations from initial discussions through post-deal alignment, and supporting technology licensing deals to enhance company pipeline and platforms. Previously, Dr. D’Cruz led and managed all aspects of academic tech transfer for Tufts University’s life science portfolio, and assisted with patent strategy, IP licenses, routine contracts, and alliance management. Dr. D’Cruz earned a Ph.D. in Neuroscience from Penn State University, a Master of Science in Engineering Management at Tufts University, and a bachelor’s degree in Biology from Drexel University.Eric Keen, Ph.D.
LinkedIn
Dr. Keen joined Flagship Pioneering in 2022 following completion of Flagship’s 2021 Fellows Program. As part of Geoffrey von Maltzahn’s origination team, Eric works to conceive and develop transformative bioplatform companies which address key challenges in health and sustainability. Eric holds a Ph.D. in Molecular Microbiology and Microbial Pathogenesis from Washington University in St. Louis, where he was a National Science Foundation Graduate Research Fellow, and a B.S. in Biology with highest honors from the University of Miami, where he was a Barry M. Goldwater Scholar. Outside of work, Eric enjoys hiking, biking, and almost anything else outdoors.Anji Miller, Ph.D. CLP RTTP
LinkedInDr Miller is a technology transfer professional with extensive experience of developing and translating early-stage translational research. Her current role at LifeArc involves working with academic and charitable establishments to identify, cultivate, fund, and commercialise early-stage healthcare technologies, focusing on rare diseases and advance therapies.
Prior to joining LifeArc, she worked for several leading establishments, including The Wellcome Trust and St George’s University of London, working at the forefront of academic translational research and knowledge transfer policy. A proponent for professional advancement in technology transfer, Dr Miller directs the LifeArc AUTM Tech Transfer Fellowship, a programme designed to train and assist scientists to become TT professionals, and she is the skills lead for the UK’s recently launched Innovation Hubs for Gene Therapy. An advocate of equality diversity and Inclusion, Dr Miller cofounded Global Equality, Diversity and Equality in Technology Transfer (GEDITT), an initiative missioned to raise awareness and promote EDI in the TT sector.
Dr Miller holds an M.Sc. in Human Molecular Genetics and Ph.D in Cancer Genetics from Imperial College, and M.Sc. and Certificate in IP Law from QMUL. She is a certified project manager, Registered Technology Transfer Professional and Certified Licensing Professional. Dr Miller serves as VP of Communities on the ASTP Board, a member of the BioIndustry Association (BIA) Cell & Gene Therapy Advisory Committee, and the AUTM Equity, Diversity & Inclusivity Committee.